These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15624229)

  • 21. Stereoselectivity behavior of the AZ28 antibody catalyzed oxy-Cope rearrangement.
    Martí S; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J
    J Phys Chem A; 2006 Jan; 110(2):726-30. PubMed ID: 16405346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms of improvement of hydrolytic antibody 6D9 by site-directed mutagenesis.
    Takahashi-Ando N; Shimazaki K; Kakinuma H; Fujii I; Nishi Y
    J Biochem; 2006 Oct; 140(4):509-15. PubMed ID: 16921165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new visual screening assay for catalytic antibodies with retro-aldol retro-Michael activity.
    Shamis M; Barbas CF; Shabat D
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1172-5. PubMed ID: 17234408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational and inhibitory analysis of a catalytic antibody. Implication for drug discovery.
    Phichith D; Bun S; Padiolleau-Lefèvre S; Banh S; Thomas D; Friboulet A; Avalle B
    Mol Immunol; 2009 Dec; 47(2-3):348-56. PubMed ID: 19828199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete reaction cycle of a cocaine catalytic antibody at atomic resolution.
    Zhu X; Dickerson TJ; Rogers CJ; Kaufmann GF; Mee JM; McKenzie KM; Janda KD; Wilson IA
    Structure; 2006 Feb; 14(2):205-16. PubMed ID: 16472740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catalytic antibodies and their applications.
    Hanson CV; Nishiyama Y; Paul S
    Curr Opin Biotechnol; 2005 Dec; 16(6):631-6. PubMed ID: 16243512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Theoretical study of catalytic efficiency of a Diels-Alderase catalytic antibody: an indirect effect produced during the maturation process.
    Martí S; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J
    Chemistry; 2008; 14(2):596-602. PubMed ID: 17960540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theory of proteolytic antibody occurrence.
    Paul S; Nishiyama Y; Planque S; Taguchi H
    Immunol Lett; 2006 Feb; 103(1):8-16. PubMed ID: 16290203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational approach to polymer-supported catalysts: synergy between catalytic reaction mechanism and polymer design.
    Madhavan N; Jones CW; Weck M
    Acc Chem Res; 2008 Sep; 41(9):1153-65. PubMed ID: 18793027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human catalytic antibody Se-scFv-B3 with high glutathione peroxidase activity.
    Huo R; Wei J; Xu J; Lv S; Zheng Q; Yan F; Su J; Fan J; Li J; Duan Y; Yu Y; Jin F; Sun W; Shi Y; Cong D; Li W; Yan G; Luo G
    J Mol Recognit; 2008; 21(5):324-9. PubMed ID: 18574795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of a pseudomerohedrally twinned monoclinic crystal form of a pyridoxal phosphate-dependent catalytic antibody.
    Golinelli-Pimpaneau B
    Acta Crystallogr D Biol Crystallogr; 2005 Apr; 61(Pt 4):472-6. PubMed ID: 15805602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanistic analysis of the phosphonate transition-state analogue-derived catalytic and non-catalytic antibody.
    Nishi Y; Yamamoto N; Shimazaki K; Takahashi-Ando N; Kakinuma H; Jialin S; Ruzheinikov SN; Muranova TA; Rice DW; Kajihara Y
    J Biochem; 2007 Oct; 142(4):421-33. PubMed ID: 17981825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biocatalysts turn rings around the competition.
    Rennie J
    Sci Am; 1994 Mar; 270(3):107. PubMed ID: 8134822
    [No Abstract]   [Full Text] [Related]  

  • 34. Generation of humanized anti-DNA hydrolyzing catalytic antibodies by complementarity determining region grafting.
    Kim DS; Lee SH; Kim JS; Lee SC; Kwon MH; Kim YS
    Biochem Biophys Res Commun; 2009 Feb; 379(2):314-8. PubMed ID: 19103171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progress in asymmetric bifunctional catalysis using multimetallic systems.
    Shibasaki M; Kanai M; Matsunaga S; Kumagai N
    Acc Chem Res; 2009 Aug; 42(8):1117-27. PubMed ID: 19435320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organolanthanide mediated catalytic cycles: a computational perspective.
    Hunt PA
    Dalton Trans; 2007 May; (18):1743-54. PubMed ID: 17471368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Catalytically active antibodies and their expected biological function].
    Nevinskiĭ GA; Kanyshkova TG; Semenov DV; Buneva VN
    Vestn Ross Akad Med Nauk; 2001; (2):38-45. PubMed ID: 11338506
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunoglobulins can utilize riboflavin (Vitamin B2) to activate the antibody-catalyzed water oxidation pathway.
    Nieva J; Kerwin L; Wentworth AD; Lerner RA; Wentworth P
    Immunol Lett; 2006 Feb; 103(1):33-8. PubMed ID: 16386801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A catalytic antibody heavy chain HpU-2 degrading its epitope peptide and H. pylori urease.
    Hifumi E; Yamada Y; Uda T
    Immunol Lett; 2006 Feb; 103(1):68-74. PubMed ID: 16321448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectroscopic signatures of nitrogen-substituted zeolites.
    Hammond KD; Dogan F; Tompsett GA; Agarwal V; Conner WC; Grey CP; Auerbach SM
    J Am Chem Soc; 2008 Nov; 130(45):14912-3. PubMed ID: 18855470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.